CIK: 0001802528 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $831,173 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC | 2,341,238 | $163,629 | 19.7% | $49.79 | +50.1% | COM | 05464T104 |
| NUVL | NUVALENT INC | 2,451,819 | $112,710 | 13.6% | $22.67 | +95.8% | COM | 670703107 |
| — | IMMUNOGEN INC | 5,929,592 | $94,103 | 11.3% | $18.87 | — | COM | 45253H101 |
| APGE | APOGEE THERAPEUTICS INC | 2,941,176 | $62,647 | 7.5% | $22.03 | 0.0% | COM | 03770N101 |
| — | MERUS N V | 1,881,345 | $44,362 | 5.3% | $24.17 | — | COM | N5749R100 |
| — | KINIKSA PHARMACEUTICALS LTD | 2,474,561 | $42,983 | 5.2% | $16.43 | — | COM CL A | G5269C101 |
| ARGX | ARGENX SE | 83,747 | $41,173 | 5.0% | $293.55 | — | SPONSORED ADR | 04016X101 |
| COGT | COGENT BIOSCIENCES INC | 3,558,975 | $34,700 | 4.2% | $9.69 | +22.4% | COM | 19240Q201 |
| SLNO | SOLENO THERAPEUTICS INC | 1,142,473 | $33,714 | 4.1% | $6.05 | 0.0% | COM | 834203309 |
| ELVN | ENLIVEN THERAPEUTICS INC | 2,131,369 | $29,115 | 3.5% | $20.33 | -17.2% | COM | 29337E102 |
| IMVT | IMMUNOVANT INC | 750,000 | $28,793 | 3.5% | $22.60 | 0.0% | COM | 45258J102 |
| — | RAYZEBIO INC | 1,221,904 | $27,126 | 3.3% | $22.20 | — | COM | 75525N107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,928,503 | $26,363 | 3.2% | $12.62 | 0.0% | COM | 252828108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,369,623 | $21,010 | 2.5% | $15.80 | +20.8% | COM | 92790C104 |
| TYRA | TYRA BIOSCIENCES INC | 1,393,329 | $19,186 | 2.3% | $14.88 | -0.4% | COM | 90240B106 |
| — | ASTRIA THERAPEUTICS INC | 1,901,397 | $14,184 | 1.7% | $11.99 | — | COM | 04635X102 |
| TRVI | TREVI THERAPEUTICS INC | 5,163,287 | $11,256 | 1.4% | $3.04 | -25.8% | COM | 89532M101 |
| TERN | TERNS PHARMACEUTICALS INC | 2,040,000 | $10,261 | 1.2% | $3.72 | +70.8% | COM | 880881107 |
| — | DBV TECHNOLOGIES SA | 6,781,150 | $9,222 | 1.1% | $2.30 | — | SPONSORED ADR | 23306J101 |
| SYRE | AEGLEA BIOTHERAPEUTICS INC | 378,421 | $4,636 | 0.6% | $13.22 | 0.0% | COM NEW | 00773J202 |